ePoster

ASTROCYTIC CERULOPLASMIN DEFICIENCY TRIGGERS IRON TOXICITY AND NEURODEGENERATION IN A LRRK2 PARKINSON’S TRI-CULTURE MODEL

Veronica Testaand 17 co-authors

Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS03-08AM-063

Presentation

Date TBA

Board: PS03-08AM-063

Poster preview

ASTROCYTIC CERULOPLASMIN DEFICIENCY TRIGGERS IRON TOXICITY AND NEURODEGENERATION IN A LRRK2 PARKINSON’S TRI-CULTURE MODEL poster preview

Event Information

Poster Board

PS03-08AM-063

Abstract

Astrocytes and microglia carrying the LRRK2-G2019S mutation contribute to non-cell-autonomous dopaminergic neuron (DAn) degeneration in Parkinson’s disease (PD), but the mechanisms underlying their interplay remain unclear. Here, we developed a novel induced pluripotent stem cell (iPSC)-derived tri-culture system comprising healthy DAn and either LRRK2-mutant or isogenic control iPSC-derived astrocytes and microglia. Using integrated functional assays and transcriptomic profiling, we found that mutant astrocytes adopt a hyperreactive state, driving microglial activation and subsequent DAn degeneration. Mechanistically, we identified a selective downregulation of ceruloplasmin (CP), a copper-dependent ferroxidase, in mutant astrocytes, leading to disrupted iron homeostasis with accumulation of Fe2+ and ROS. This iron dysregulation mediated both microglial reactivity and neurodegeneration. Notably, pharmacological restoration of CP re-established iron homeostasis, reduced microglial activation, and protected DAn from degeneration. Our findings uncover a novel astrocyte-microglia-neuron axis driving PD pathogenesis and showcase the power of our unique stem cell tri-culture platform for dissecting disease mechanisms and discovering therapeutic targets.

Recommended posters

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.